  Drug delivery systems represent a promising strategy to treat cancer and to
overcome the side effects of chemotherapy. In particular, polymeric
nanocontainers have attracted major interest because of their structural and
morphological advantages and the variety of polymers that can be used, allowing
the synthesis of materials capable of responding to the biochemical alterations
of the tumour microenvironment. While experimental methodologies can provide
much insight, the generation of experimental data across a wide parameter space
is usually prohibitively time consuming and/or expensive. To better understand
the influence of varying design parameters on the drug release profile and drug
kinetics involved, appropriately-designed mathematical models are of great
benefit. Here, we developed a novel mathematical model to describe drug
transport within, and release from, a hollow nanocontainer consisting of a core
and a pH-responsive polymeric shell. The two-layer mathematical model fully
accounts for drug dissolution, diffusion and interaction with polymer. We
generated experimental drug release profiles using daunorubicin and
[Cu(TPMA)(Phenantroline)](ClO_4)_2 as model drugs, for which the nanocontainers
exhibited excellent encapsulation ability. The in vitro drug release behaviour
was studied under different conditions, where the system proved capable of
responding to the selected pH stimuli by releasing a larger amount of drug in
an acidic than in the physiological environments. By comparing the results of
the mathematical model with our experimental data, we were able to identify the
model parameter values that best-fit the data and demonstrate that the model is
capable of describing the phenomena at hand. The proposed methodology can be
used to describe and predict the release profiles for a variety of drug
delivery systems.
